- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Isatuximab Carfilzomib Lenalidomide Dexamethasone
Total 487 results
-
Medical College of WisconsinRecruitingMultiple MyelomaUnited States
-
Ascentage Pharma Group Inc.Recruiting
-
University Hospital, LimogesMinistry of Health, France; Celgene CorporationCompleted
-
M.D. Anderson Cancer CenterCelgene; Onyx Therapeutics, Inc.Terminated
-
Celgene CorporationPrologue Research InternationalCompletedMultiple MyelomaUnited States, Canada
-
Peng LiuChipscreen Biosciences, Ltd.Unknown
-
Chiba UniversityCompleted
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaUnited States, Spain, France, Greece
-
Teva takedaActive, not recruitingMultiple MyelomaUnited States, Spain, Belgium, Israel
-
Institut de Cancérologie de la LoireCelgene CorporationCompletedLeukemia, Lymphoid | Precursor B-Cell Lymphoblastic Leukemia-LymphomaFrance
-
Arbeitsgemeinschaft medikamentoese TumortherapieAmgenCompletedMultiple MyelomaAustria, Germany
-
University of Alabama at BirminghamRecruitingMultiple MyelomaUnited States
-
JW PharmaceuticalCompletedMultiple MyelomaKorea, Republic of, United States
-
PETHEMA FoundationCelgene CorporationCompleted
-
Bristol-Myers SquibbNo longer available
-
University Hospital, LilleActive, not recruiting
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaTaiwan
-
Anaveon AGTerminatedHematologic Diseases | Multiple Myeloma | Refractory Multiple Myeloma | Adult Disease | Relapsed CancerSpain, Germany, France, Denmark, Switzerland
-
Fondazione Italiana Linfomi ONLUSCompletedDiffuse Large B-cells Non-Hodgkin LymphomaItaly
-
AbbVieGenentech, Inc.; Celgene CorporationWithdrawnMultiple MyelomaUnited States, Australia, Canada, Spain
-
European Myeloma NetworkJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaNorway, Denmark, Netherlands, Czechia, Australia, Turkey, Spain, Belgium, Switzerland, France, Greece, Italy, Poland
-
University of Heidelberg Medical CenterBristol-Myers Squibb; Sanofi; Wuerzburg University Hospital; KKS NetzwerkRecruiting
-
SanofiRecruitingPlasma Cell Myeloma RecurrentUnited States, Argentina, Australia, Brazil, Canada, Chile, China, Czechia, France, Germany, Greece, Hungary, Italy, Japan, Norway, Poland, Spain, Sweden, Taiwan, Turkey, United Kingdom
-
TakedaCompleted
-
CelgeneCompletedMultiple MyelomaKorea, Republic of, United States, France, Belgium, Canada, Spain, United Kingdom, Australia, Italy, New Zealand, China, Portugal, Switzerland, Taiwan, Austria, Greece, Germany, Ireland, Sweden
-
Merck Sharp & Dohme LLCTerminated
-
PETHEMA FoundationCelgene Corporation; AmgenActive, not recruitingSmoldering Multiple MyelomaSpain
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI); Blood and Marrow Transplant Clinical Trials...CompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityCelgeneTerminated
-
Seagen Inc.Genentech, Inc.CompletedMultiple MyelomaUnited States
-
Ascentage Pharma Group Inc.RecruitingMultiple Myeloma | AmyloidosisUnited States
-
Hellenic Society of HematologySanofiNot yet recruitingNeoplasms | Neoplasms by Histologic Type | Hematologic Diseases | Multiple Myeloma | Neoplasms, Plasma Cell | Paraproteinemias | Blood Protein Disorders | Renal ImpairmentGreece
-
PfizerActive, not recruitingLymphoma | Diffuse Large B-Cell Lymphoma | Acute Myeloid Leukemia | Multiple MyelomaUnited States
-
Incyte CorporationTerminatedMetastatic Cancer | Solid Tumors | Advanced MalignanciesUnited States
-
Institute of Hematology & Blood Diseases Hospital...Recruiting
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Attaya SuvannasankhaNational Cancer Institute (NCI)TerminatedRefractory Multiple MyelomaUnited States
-
Kosin University Gospel HospitalRecruitingWaldenström's MacroglobulinemiaKorea, Republic of
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Australia, France, Japan, Netherlands, Poland, Spain, Sweden, Greece, Canada, Korea, Republic of, Germany, Brazil, Israel, Mexico, Norway, Russian Federation
-
Weill Medical College of Cornell UniversityOnyx Therapeutics, Inc.Active, not recruiting
-
Abramson Cancer Center at Penn MedicineCompletedFollicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle-Cell Lymphoma | Lymphoma, Small Lymphocytic | Marginal Zone B-Cell Lymphoma | MALT Lymphoma | Lymphoma of Mucosa-Associated Lymphoid TissueUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; AmgenWithdrawn
-
Ida Bruun KristensenOdense Patient Data Explorative Network; Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaDenmark, Norway, Estonia
-
H. Lee Moffitt Cancer Center and Research InstituteJanssen Scientific Affairs, LLCActive, not recruitingMultiple MyelomaUnited States
-
Washington University School of MedicineSanofiTerminatedMultiple MyelomaUnited States
-
University of WashingtonGenzyme, a Sanofi CompanyRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
PfizerCompletedMultiple MyelomaCanada, United States
-
Mario BoccadoroActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterUniversity of NebraskaCompletedT-cell Lymphomas | Relapsed or RefractoryUnited States
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada